(Overview) Molecular Tumor Board: Resistance to Checkpoint Inhibitors Part 2 Published 2019-01-29 Download video MP4 360p Download video MP4 720p Recommendations 1:05:36 Part 1 - Molecular and Precision Medicine (MAP) Series 02:51 Ultra-long-term drug delivery 03:38 (Overview) CAR-T Cell Therapy of Ovarian Cancer 55:15 Dr. Jeff Yu and Allergic Contact Dermatitis 1:48:15 The Fasting Expert: 40-Day Water-Only Fasting Could SAVE Your LIFE | Dr. Alan Goldhamer 18:40 Matthew Perry's Death From Ketamine Explained (Is It Safe For You?) 02:06 Signs and Symptoms of a Brain Tumor | Dana-Farber Cancer Institute 04:29 Becoming a Toxicologist 1:01:48 Part 3 - Molecular and Precision Medicine (MAP) Series 53:54 Mitochondria - The Key To Disease and Mental Health with Dr. Martin Picard 1:07:43 Part 5 - Molecular and Precision Medicine (MAP) Series 24:43 Putin 'is done' as losses in Ukraine degrade Kremlin's force projection | Peter Zeihan 59:22 Leading as a Surgeon by Day, Writer by Night | Atul Gawande | Voices in Leadership 03:03 (Overview) Targeting Cell Death Pathways with Precision Using Functional Assays 04:31 Understanding Parkinson's disease 27:35 Clarifying the Confusing Truth About Depression and Borderline Personality Disorder (BPD) 02:28 (Overview) Beyond PARP1: Ribosylation as a Target for Cancer Therapy 48:11 Brain Energy, Mitochondria, and Mental Health with Dr. Chris Palmer 01:03 Meet HSCI Co-Director Douglas Melton, PhD 06:21 Causes and Treatment of Erectile Dysfunction Video – Brigham and Women’s Hospital Similar videos 41:46 Molecular Tumor Board 01:07 Checkpoint inhibitors for lung cancer: combating resistance 1:03:18 September 24, 2022, Revolution Cancer International Molecular Tumor Board- NOVARTIS, MET, mdm2, MSI 47:00 Frontiers in Oncology - Antoni Ribas, MD, PhD 40:33 Challenges to Precision Medicine for Anti-Cancer Immunotherapy 53:09 Frontiers in Oncology - Michael Lim, MD 58:38 2021 OneOncology | Advancing Precision Oncology in the Community | Molecular Tumor Board 04:56 Molecular Tumor Board - Thoracic ARID1A and PD-L1 present 01:46 Predicting response to checkpoint inhibitors and overcoming resistance in lung cancers 40:55 J. Michael Bishop (UCSF) Part 3: The cancer genome and therapeutics 1:04:55 At the Crossroads of Epigenetics and Angiogenesis Targeting the Undruggable 58:49 Curing metastatic solid tumours with immune checkpoint inhibitors by Professor James Larkin 36:42 October 8, 2022, Revolution Cancer International Molecular Tumor Board - Merck, MSI-High CRC, NTRK 25:05 Improving response to immune checkpoint inhibitors 19:31 Panel Q&A Session on Acquired Resistance with Drs. Riely & Horn 03:15 Molecular tumor boards for personalized medicine 01:27 Analyzing the Role of Checkpoint Inhibitors for the Treatment of Melanoma 44:15 June 7, 2021 | Investigating Mechanisms of Response & Resistance to Immune Checkpoint Therapy 02:05 Immunotherapy resistance mechanisms and predicting NMIBC patient immune responses. More results